Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hui-Ying Liu
Bone Marrow Molecular Markers Associated With Relapsed/Refractory Activated B-Cell-Like Diffuse Large B-Cell Lymphoma
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Related publications
Direct Costs Associated With Relapsed Diffuse Large B‐Cell Lymphoma Therapies
Oncologist
Cancer Research
Medicine
Oncology
Molecular Landscape of Relapse/Refractory Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Annals of Hematology
Medicine
Hematology
Ets1 Positively Regulates Faim3 in Activated B Cell-Like (Abc) Diffuse Large B Cell Lymphoma (Dlbcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Emerging Therapies for the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma
Current Oncology
Oncology
Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma
Seminars in Diagnostic Pathology
Forensic Medicine
Pathology
Diffuse Large B-Cell Lymphoma
The Proportion of Activated B-Cell Like Subtype Among De Novo Diffuse Large B-Cell Lymphoma Increases With Age
Haematologica
Hematology
Diffuse Large B-Cell Lymphoma Presenting With Cholecystitis-Like Symptoms
Korean Journal of Clinical Oncology